These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 12788181

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Int J Radiat Oncol Biol Phys; 2002 Mar 01; 52(3):664-73. PubMed ID: 11849788
    [Abstract] [Full Text] [Related]

  • 5. The role of external radiotherapy in patients treated with permanent prostate brachytherapy.
    Potters L, Fearn P, Kattan M.
    Prostate Cancer Prostatic Dis; 2002 Mar 01; 5(1):47-53. PubMed ID: 15195130
    [Abstract] [Full Text] [Related]

  • 6. 12-year outcomes following permanent prostate brachytherapy in patients with clinically localized prostate cancer.
    Potters L, Morgenstern C, Calugaru E, Fearn P, Jassal A, Presser J, Mullen E.
    J Urol; 2005 May 01; 173(5):1562-6. PubMed ID: 15821486
    [Abstract] [Full Text] [Related]

  • 7. Isotope selection for patients undergoing prostate brachytherapy.
    Cha CM, Potters L, Ashley R, Freeman K, Wang XH, Waldbaum R, Leibel S.
    Int J Radiat Oncol Biol Phys; 1999 Sep 01; 45(2):391-5. PubMed ID: 10487561
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Potency after permanent prostate brachytherapy for localized prostate cancer.
    Potters L, Torre T, Fearn PA, Leibel SA, Kattan MW.
    Int J Radiat Oncol Biol Phys; 2001 Aug 01; 50(5):1235-42. PubMed ID: 11483334
    [Abstract] [Full Text] [Related]

  • 13. Examining the role of neoadjuvant androgen deprivation in patients undergoing prostate brachytherapy.
    Potters L, Torre T, Ashley R, Leibel S.
    J Clin Oncol; 2000 Mar 01; 18(6):1187-92. PubMed ID: 10715287
    [Abstract] [Full Text] [Related]

  • 14. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L, Purrazzella R, Brustein S, Fearn P, Leibel SA, Kattan MW.
    Cancer; 2002 Oct 01; 95(7):1451-6. PubMed ID: 12237913
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Perineural invasion is not predictive of biochemical outcome following prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.
    Cancer J; 2001 Oct 01; 7(5):404-12. PubMed ID: 11693899
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prostate specific antigen findings and biopsy results following interactive ultrasound guided transperineal brachytherapy for early stage prostate carcinoma.
    Stock RG, Stone NN, DeWyngaert JK, Lavagnini P, Unger PD.
    Cancer; 1996 Jun 01; 77(11):2386-92. PubMed ID: 8635111
    [Abstract] [Full Text] [Related]

  • 20. Primary Gleason grade 4 impact on biochemical recurrence after permanent interstitial brachytherapy in Japanese patients with low- or intermediate-risk prostate cancer.
    Uesugi T, Saika T, Edamura K, Nose H, Kobuke M, Ebara S, Abarzua F, Katayama N, Yanai H, Nasu Y, Kumon H.
    Int J Radiat Oncol Biol Phys; 2012 Feb 01; 82(2):e219-23. PubMed ID: 21640517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.